1,8-Diazabicyclo[5.4.0]undec-7-ene | CAS:6674-22-2 99.0% bulk supply

We serve 1,8-Diazabicyclo[5.4.0]undec-7-ene CAS:6674-22-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Chemical Name:1,8-Diazabicyclo[5.4.0]undec-7-ene

CAS.NO:6674-22-2

Synonyms:2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine;DBU

Molecular Formula:C9H16N2

Molecular Weight:152.23700

Physical and Chemical Properties:

Density:1.019;

Melting point:-70oC;

Boiling point:80-83oC;

Flash point:116oC;

Index of Refraction:1.523;

HS Code: 2933990099

UN No.: UN3267

Hazard class: 8 categories

Packing level: Class II

Specification:

Appearance:Light yellow to colorless liquid

Purity(GC):≥98.0%

Packing:200 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:As a condensation reagent

Contact us for information like 1,8-Diazabicyclo[5.4.0]undec-7-ene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DBU physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,8-Diazabicyclo[5.4.0]undec-7-ene Use and application,1,8-Diazabicyclo[5.4.0]undec-7-ene technical grade,usp/ep/jp grade.

Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.Dichlorodiphenylsilane manufacturer Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.1-Fluoronaphthalene supplier Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.9-(4-broMophenyl)-10-(naphthalen-1-yl)anthracene vendor Dr Maria Van Kerkhove, of the WHO’s emerging diseases unit, says it is important that you keep up basic hand and respiratory hygiene, such as washing your hands with soap and water and sneezing into your elbow or a tissue.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.